Despite the availability of approximately 25 drugs for the treatment of breast cancer, the unmet need in the global market is vast. To address this drawback, pharmaceutical companies have established a robust pipeline that currently has about 52 drugs in development

Read the original post:
Global breast cancer therapeutics market estimated to reach $13.38 billion in 2018

Scroll to Top